Effect of Different Corticosteroid Regimens on the Outcome of Severe COVID-19-Related Acute Respiratory Failure. A Retrospective Analysis
Background: Systemic corticosteroids are associated with reduced mortality in COVID-19-related acute respiratory failure; however, the type and dose has not yet been established. Objectives: To compare the outcomes of dexamethasone vs. methylprednisolone, along with the effects of rescue, short-term...
Guardado en:
Autores principales: | Michele Umbrello, Paolo Formenti, Stefano Nespoli, Eleonora Pisano, Cecilia Bonino, Stefano Muttini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8aba2da3dac94ea3ae82c0e79a04ea8e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology
por: Maria Vargas, et al.
Publicado: (2021) -
Dismal Survival in COVID-19 Patients Requiring ECMO as Rescue Therapy after Corticosteroid Failure
por: Sebastian Voicu, et al.
Publicado: (2021) -
Rapid successful management of diffuse alveolar hemorrhage as the primary presentation of chlorine gas inhalation; A rare case report
por: samaneh kakhki, et al.
Publicado: (2021) -
Acute Respiratory Distress Syndrome: Focus on Viral Origin and Role of Pulmonary Lymphatics
por: Eleonore Fröhlich
Publicado: (2021) -
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
por: Seyed MohammadReza Hashemian, et al.
Publicado: (2021)